Showing results (1311-1320 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|March 23, 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantationKhalil Saleh, Ahmadreza Arbab, David Ghez, et al.
Immunotherapy|March 23, 2023
Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance studyYinghong Zhai, Fangyuan Hu, Borui Zhu, et al.
Immunotherapy|August 21, 2025
Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature reviewDante Pio Pallotta, Bernardo Stefanini, Agnese Pratelli, et al.
Immunotherapy|January 28, 2026
A case report of breast cancer recurrence with cystitis: the impact of immune checkpoint inhibitor therapy on the incidence of cystitisJieqing Li, Yingyi Lin
Immunotherapy|January 14, 2026
Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional studyBeliz Bahar Karaoğlan, Filiz Çay Şenler
Immunotherapy|November 20, 2025
Sublingual immunotherapy suppresses Th2-type immune response in the allergic rhinitis mouse model by inhibiting the activation of the NFκB pathwayGan Wang, Zhiling Chen
Immunotherapy|November 1, 2025
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trialsCourtney H Coschi, Keyue Ding, Dongsheng Tu, et al.
Immunotherapy|November 5, 2025
Remarkable response to anti-PD-L1 blockade in relapsed and refractory metastatic malignant giant cell tumor of bone: a case reportJerry T Wu, Jarrell Imamura, Elizabeth Nowak, et al.
Immunotherapy|July 14, 2025
Chemotherapy-free treatment of B-lymphoid/myeloid mixed phenotype acute leukemia: two case reports and literature reviewYi-Fan Wang, Jing-Ying Dai, Ming-Yong Li, et al.
Immunotherapy|July 4, 2025
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) studySerhat Sekmek, Hatice Bolek, Omer Faruk Kuzu, et al.
Pageof 188